Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Chinese Medicine
  4. Vol 8, Issue 1, 2026

Research Progress on Improving Perimenopausal Syndrome with Chinese Herbal Compounds

Download as PDF

DOI: 10.23977/medcm.2026.080105 | Downloads: 0 | Views: 34

Author(s)

Tingting Wang 1, Tonghua Liu 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, 712046, Shaanxi, China
2 Beijing University of Chinese Medicine, Beijing, 100029, China

Corresponding Author

Tonghua Liu

ABSTRACT

Perimenopausal syndrome is a physiological and psychological syndrome induced by declining ovarian function and fluctuations in sex hormones during the transition from the reproductive period to menopause, which severely affects women's physical health. Traditional Chinese Medicine has unique advantages in treating this condition, as it can effectively alleviate clinical symptoms, delay disease progression, and reduce side effects associated with Western medicine. Traditional Chinese Medicine adheres to the principles of holistic concept and syndrome differentiation. This paper selects classical prescriptions and empirical prescriptions from Traditional Chinese Medicine compounds. This approach reviews classical and empirical prescripyions. Their multi-target and multi-pathway mechanism of action provides a favorable option for managing this condition.

KEYWORDS

Perimenopausal Syndrome, Chinese Herbal Compound, Classical Prescription, Empirical Prescription

CITE THIS PAPER

Tingting Wang, Tonghua Liu. Research Progress on Improving Perimenopausal Syndrome with Chinese Herbal Compounds. MEDS Chinese Medicine (2026) Vol. 8: 31-36. DOI: http://dx.doi.org/10.23977/medcm.2026.080105.

REFERENCES

[1] Santoro, N., Roeca, C., Peters, B.A. and Neal-Perry, G. (2021) The Menopause Transition: Signs, Symptoms, and Management Options. The Journal of Clinical Endocrinology and Metabolism, 106(1), 1–15.
[2] Crandall, C.J., Mehta, J.M. and Manson, J.E. (2023) Management of Menopausal Symptoms: A Review. JAMA, 329(5), 405–420.
[3] Wang, Y.P. and Yu, Q. (2021) The Treatment of Menopausal Symptoms by Traditional Chinese Medicine in Asian Countries. Climacteric, 24(1), 64–67.
[4] Talaulikar, V. (2022) Menopause Transition: Physiology and Symptoms. Best Practice & Research Clinical Obstetrics & Gynaecology, 81, 3–7.
[5] Zhang, X., Luo, L., Wang, C., Lv, W., Duan, Y. and Kong, L. (2024) Research Progress on Chaihu Shugan San in Treating Perimenopausal Syndrome: A Review. Medicine, 103(52), e41044.
[6] Lyu, H., Li, T., Chen, Y., Xue, Y., Liu, W., Yuan, Y., Chen, S., Lu, D., Ren, Y., Wang, H., Cao, F., Wu, C., Chen, B. and Chen, X. (2026) Exploring the Effective Substances and Mechanisms of Action of ChaiHu ShuGan San in Treating Perimenopausal Syndrome Based on in Vivo Exposure Profiles and Steroid Hormone Metabolic Networks. Journal of Ethnopharmacology, 355(Pt A), 120648.
[7] Chen, Q., Li, C., Tao, E., Asakawa, T. and Zhang, Y. (2022) Exploration of a Brain-Liver-Communication-Related Mechanism Involved in the Experimental Perimenopausal Depression Rat Model Using Chaihu-Shugan-San. Neurochemical Research, 47(5), 1354–1368.
[8] Huang, R., Gong, M., Tan, X., Shen, J., Wu, Y., Cai, X., Wang, S., Min, L., Gong, L. and Liang, W. (2024) Effects of Chaihu Shugan San on Brain Functional Network Connectivity in the Hippocampus of a Perimenopausal Depression Rat Model. Molecular Neurobiology, 61(3), 1655–1672.
[9] Wang, T., Li, Z., Chen, T., Cai, R., Jiang, Y., Ofori, P.K., Zhang, H. and Wu, Y. (2023) Zuogui and Yougui Pills Improve Perimenopausal Syndrome by Regulating Apoptosis in Mice. Journal of Traditional Chinese Medicine, 43(3), 474–483.
[10] Zhang, L., Li, J., Chen, Q., Di, L. and Li, N. (2021) Erxian Decoction, a Famous Chinese Medicine Formula, Ameliorates Depression-Like Behavior in Perimenopausal Mice. Endocrine, Metabolic & Immune Disorders Drug Targets, 21(12), 2203–2212.
[11] Xue, B., Chen, X., Wang, X., Li, C., Liu, J., He, Q. and Liu, E. (2022) Application of Multivariate Statistical Analysis and Network Pharmacology to Explore the Mechanism of Danggui Liuhuang Tang in Treating Perimenopausal Syndrome. Journal of Ethnopharmacology, 284, 114543.
[12] Xiong, J.L., Cai, X.Y., Zhang, Z.J., Li, Q., Zhou, Q. and Wang, Z.T. (2022) Elucidating the Estrogen-Like Effects and Biocompatibility of the Herbal Components in the Qing’e Formula. Journal of Ethnopharmacology, 283, 114735.
[13] Zhou, G., Chen, D., Qian, L., Song, D., Zhang, Q., Yan, Y., Lin, J., Li, L., Wan, G., Li, S., Hou, L., He, Y., Qi, C. and Yuan, W. (2025) Efficacy and Safety of Kunxinning Granules in Patients with Menopausal Syndrome: A Multicenter, Randomized, Double-Blinded, and Placebo-Controlled Trial. Frontiers in Pharmacology, 16, 1512110.
[14] Wu, X., Zhou, L., Dong, H., Tian, M., Liu, S. and Xu, X. (2022) Efficacy, Safety and Mechanism of Honghua Xiaoyao Pill in the Treatment of Perimenopausal Syndrome: A Study Protocol for a Randomized Controlled Trial. Frontiers in Pharmacology, 13, 1001228.
[15] Tang, B.X., Meng, Q.Y., Xie, C., Zhao, S.S., Wu, K.L., Wang, F. and Du, L.Y. (2020) Ziyin Bushen Decoction Alleviates Perimenopausal Syndrome in Rats by Enhancing Estradiol Production. Evidence-Based Complementary and Alternative Medicine, 2020, 8895809.
[16] Zheng, A., Zhang, L., Jiang, Y., Yu, S., Li, X. and Han, C. (2025) Chaishen Powder Treats Perimenopausal Syndrome Through the PI3K-Akt/cAMP Signaling Pathway: Integrated Clinical Analysis, Network Pharmacology, MicroRNA and Animal Experiment. Climacteric, 1–18.
[17] Lv, X., Bi, A., Zhang, Z., Li, J., Wei, Y., Wan, M., Wang, J., Yan, T. and Jia, Y. (2024) Non-Targeted Metabolomics Strategy Reveals the Role of Gengnian Shu in Regulating Ferroptosis in Perimenopausal Syndrome. Journal of Pharmaceutical and Biomedical Analysis, 241, 115980.
[18] Liu, G.X., Zhang, G.D. and Yan, Z.Y. (2024) Efficacy and Potential Mechanisms of Ganmai Dazao Decoction in Treating Perimenopausal Syndrome: A Network Pharmacology and Meta-Analysis. Asian Journal of Surgery, 47(7), 3065–3067.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 9791
Visits: 679077

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.